Acute Myeloid Leukemia Clinical Trials Near Me
As of October 19, 2026, 708 Acute Myeloid Leukemia clinical trials are recruiting or about to open (546 recruiting now, 162 opening soon). 304 of them have at least 1 open site in the United States, across 51 states. Enter your ZIP code to see which are closest to you.
Also on Trial Friend:Acute Myeloid Leukemia pageMatch Me
All 546 Acute Myeloid Leukemia trials and their US sites
Enter your ZIP code above to sort them by how far their nearest open site is from you.
- Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer DetectionAnchorage Associates in Radiation Medicine, Anchorage, Alaska; Alaska Breast Care and Surgery LLC, Anchorage, Alaska; Alaska Oncology and Hematology LLC, Anchorage, Alaska and 607 more sitesRecruitingAges 40 to 75Run by Alliance for Clinical Trials in Oncology
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)University of Alabama at Birmingham Cancer Center, Birmingham, Alabama; Mayo Clinic Hospital in Arizona, Phoenix, Arizona; Banner University Medical Center - Tucson, Tucson, Arizona and 320 more sitesRecruitingPhase 2Ages 18+Run by National Cancer Institute (NCI)
- Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)University of Alabama at Birmingham Cancer Center, Birmingham, Alabama; Banner University Medical Center - Tucson, Tucson, Arizona; University of Arizona Cancer Center-North Campus, Tucson, Arizona and 208 more sitesRecruitingPhase 2Ages 18+Run by National Cancer Institute (NCI)
- Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)University of Alabama at Birmingham Cancer Center, Birmingham, Alabama; Mayo Clinic Hospital in Arizona, Phoenix, Arizona; Banner University Medical Center - Tucson, Tucson, Arizona and 200 more sitesRecruitingPhase 2Ages 18 to 59Run by National Cancer Institute (NCI)
- A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsChildren's Hospital of Alabama, Birmingham, Alabama; USA Health Strada Patient Care Center, Mobile, Alabama; Banner Children's at Desert, Mesa, Arizona and 169 more sitesRecruitingPhase 3Ages 6 Months to 21Run by Children's Oncology Group
- Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)University of Alabama at Birmingham Cancer Center, Birmingham, Alabama; Banner University Medical Center - Tucson, Tucson, Arizona; University of Arizona Cancer Center-North Campus, Tucson, Arizona and 162 more sitesRecruitingPhase 2Ages 18 to 59Run by National Cancer Institute (NCI)
- The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group StudyChildren's Hospital of Alabama, Birmingham, Alabama; USA Health Strada Patient Care Center, Mobile, Alabama; Providence Alaska Medical Center, Anchorage, Alaska and 153 more sitesRecruitingPhase 1/2Up to age 22Run by PedAL BCU, LLC
- Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)Banner University Medical Center - Tucson, Tucson, Arizona; University of Arizona Cancer Center-North Campus, Tucson, Arizona; University of Arkansas for Medical Sciences, Little Rock, Arkansas and 122 more sitesRecruitingPhase 2Ages 18+Run by National Cancer Institute (NCI)
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)University of Alabama at Birmingham, Birmingham, Alabama; Banner MD Anderson Cancer Center, Gilbert, Arizona; Phoenix Children's Hospital, Phoenix, Arizona and 108 more sitesRecruitingRun by Center for International Blood and Marrow Transplant Research
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial)University of Alabama at Birmingham Cancer Center, Birmingham, Alabama; UC San Diego Moores Cancer Center, La Jolla, California; Memorial Hospital West, Pembroke Pines, Florida and 67 more sitesRecruitingPhase 2Ages 18 to 59Run by National Cancer Institute (NCI)
- A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)University of Alabama at Birmingham, Birmingham, Alabama; Cancer Treatment Center of America Phoenix, Goodyear, Arizona; The University of Arizona Cancer Center, Tucson, Arizona and 56 more sitesRecruitingPhase 3Ages 18+Run by Janssen Research & Development, LLC
- Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)Phoenix Children's Hospital, Phoenix, Arizona; Arkansas Children's Hospital, Little Rock, Arkansas; MemorialCare Miller Children's and Women's Hospital Long Beach, Long Beach, California and 42 more sitesRecruitingPhase 3Ages 29 Days to 21Run by PedAL BCU, LLC
- A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AMLMayo Clinic - Phoenix, Phoenix, Arizona; Moores UC San Diego Cancer Center, La Jolla, California; USC / Norris Comprehensive Cancer Center, Los Angeles, California and 41 more sitesRecruitingPhase 1Ages 18+Run by Kura Oncology, Inc.
- Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLBanner MD Anderson Cancer Center, Gilbert, Arizona; University of California, Fresno, Clovis, California; University of California, San Diego, La Jolla, California and 41 more sitesRecruitingPhase 3Ages 18+Run by Kura Oncology, Inc.
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid LeukemiaChildren's Hospital of Alabama, Birmingham, Alabama; Arkansas Children's Hospital, Little Rock, Arkansas; Valley Children's Hospital, Madera, California and 36 more sitesRecruitingPhase 3Ages 1 to 25Run by Children's Oncology Group
- Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)Kootenai Health - Coeur d'Alene, Coeur d'Alene, Idaho; Kootenai Clinic Cancer Services - Post Falls, Post Falls, Idaho; Kootenai Clinic Cancer Services - Sandpoint, Sandpoint, Idaho and 35 more sitesRecruitingPhase 2Ages 60+Run by National Cancer Institute (NCI)
- Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaBanner MD Anderson Cancer Center, Gilbert, Arizona; USC Norris Comprehensive Cancer Center, Los Angeles, California; UCLA Health - Bowyer Oncology Center, Los Angeles, California and 33 more sitesRecruitingPhase 1Ages 18+Run by Kura Oncology, Inc.
- A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)Hoag Family Cancer Center, Newport Beach, California; Stanford University, Palo Alto, California; Colorado Blood Cancer Institute, Denver, Colorado and 27 more sitesRecruitingPhase 1/2Ages 12+Run by Sumitomo Pharma America, Inc.
- Study of Biomarker-Based Treatment of Acute Myeloid LeukemiaMayo Clinic - Scottsdale, Scottsdale, Arizona; UCLA Ronald Reagan Medical Center, Los Angeles, California; University of California, San Francisco, San Francisco, California and 24 more sitesRecruitingPhase 2/3Ages 18+Run by Beat AML, LLC
- A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)Keck School of Medicine of USC, Los Angeles, California; UC Irvine Health - Chao Family Comprehensive Cancer Center, Orange, California; Yale University, New Haven, Connecticut and 19 more sitesRecruitingPhase 2/3Ages 18+Run by Taiho Oncology, Inc.
New trials, status changes and new sites, straight from ClinicalTrials.gov. Unsubscribe anytime.
You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Acute Myeloid Leukemia. Turn any of these off from the link in every email.
Where Acute Myeloid Leukemia trials are recruiting in the US
The US cities with the most Acute Myeloid Leukemia trials recruiting are Houston, Texas (97), New York, New York (56), Boston, Massachusetts (48), Seattle, Washington (46) and Duarte, California (42), counting trials with at least 1 open site in each city.
Hospitals that run trials for a rare condition often see more people with it than most clinics do, so this list can also help you find doctors who know Acute Myeloid Leukemia, even if no trial fits you.
- MD Anderson Cancer Center
- M D Anderson Cancer Center
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center
- and 26 more
- Memorial Sloan Kettering Cancer Center
- Memorial Sloan Kettering Cancer Center (All Protocol Activities)
- Icahn School of Medicine at Mount Sinai
- and 36 more
- Dana-Farber Cancer Institute
- Dana Farber Cancer Institute
- Massachusetts General Hospital
- and 11 more
- Fred Hutch/University of Washington Cancer Consortium
- Fred Hutchinson Cancer Center
- Swedish Medical Center-First Hill
- and 11 more
- City of Hope Medical Center
- City of Hope
- City of Hope Comprehensive Cancer Center
- and 9 more
- Ohio State University Comprehensive Cancer Center
- Nationwide Children's Hospital
- Ohio State University
- and 16 more
- Children's Healthcare of Atlanta - Arthur M Blank Hospital
- Emory University
- Children's Healthcare of Atlanta
- and 19 more
- Children's Hospital of Philadelphia
- Thomas Jefferson University Hospital
- University of Pennsylvania
- and 10 more
States with at least 1 open site: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.
Questions about finding an Acute Myeloid Leukemia trial near you
Are there Acute Myeloid Leukemia clinical trials near me?
As of October 19, 2026, 708 Acute Myeloid Leukemia clinical trials are recruiting or about to open (546 recruiting now, 162 opening soon). 304 of them have at least 1 open site in the United States, across 51 states. Enter your ZIP code on this page to rank every one of them by the distance to its closest open site, with the sites shown on a map.
Which states have Acute Myeloid Leukemia clinical trial sites?
As of October 19, 2026, recruiting Acute Myeloid Leukemia trials list open sites in 51 states. The US cities with the most Acute Myeloid Leukemia trials recruiting are Houston, Texas (97), New York, New York (56), Boston, Massachusetts (48), Seattle, Washington (46) and Duarte, California (42), counting trials with at least 1 open site in each city.
What if there is no Acute Myeloid Leukemia trial near me?
Some trials pay for or reimburse travel and lodging, and a few send staff or use local labs so fewer visits happen at the study site, so ask the study contact before ruling a trial out. You can also sign up on this page to get an email when an Acute Myeloid Leukemia trial opens a new site or changes status.
How is the distance to a trial site measured?
Distances are straight-line miles from the center of your ZIP code to each study site's listed location, not driving distance. Your browser looks up the ZIP code's coordinates with a free map service, Zippopotam.us, and the ZIP code is never sent to or stored by Trial Friend.
FDA-approved for Acute Myeloid Leukemia: Cytarabine, Daunorubicin, Daurismo (glasdegib), Idamycin PFS (idarubicin), Idhifa (enasidenib), Inqovi (decitabine and cedazuridine), Komzifti (ziftomenib), Mylotarg (gemtuzumab ozogamicin) and 11 more on the disease page.
Source: ClinicalTrials.gov, trials with status Recruiting or Not yet recruiting. Refreshed every 6 hours; counts as of October 19, 2026. Sites that ClinicalTrials.gov lists as closed or withdrawn are left out.